Bridgeway Capital Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-51,600
| Closed | -$1.94M | – | 1433 |
|
|
2021
Q1 | $1.94M | Sell |
51,600
-79,900
| -61% | -$3.01M | 0.04% | 629 |
|
|
2020
Q4 | $2.24M | Hold |
131,500
| – | – | 0.05% | 486 |
|
|
2020
Q3 | $618K | Sell |
131,500
-35,000
| -21% | -$164K | 0.01% | 819 |
|
|
2020
Q2 | $1.02M | Buy |
166,500
+45,000
| +37% | +$275K | 0.02% | 649 |
|
|
2020
Q1 | $276K | Sell |
121,500
-25,000
| -17% | -$56.8K | 0.01% | 958 |
|
|
2019
Q4 | $672K | Buy |
146,500
+96,500
| +193% | +$443K | 0.01% | 852 |
|
|
2019
Q3 | $194K | Buy |
+50,000
| New | +$194K | ﹤0.01% | 1187 |
|
|
2017
Q2 | – | Sell |
-8,800
| Closed | -$318K | – | 1492 |
|
|
2017
Q1 | $318K | Buy |
+8,800
| New | +$318K | ﹤0.01% | 1196 |
|
|
2016
Q1 | – | Sell |
-5,000
| Closed | -$208K | – | 1497 |
|
|
2015
Q4 | $208K | Sell |
5,000
-35,000
| -88% | -$1.46M | ﹤0.01% | 1291 |
|
|
2015
Q3 | $616K | Hold |
40,000
| – | – | 0.01% | 935 |
|
|
2015
Q2 | $994K | Hold |
40,000
| – | – | 0.02% | 792 |
|
|
2015
Q1 | $914K | Sell |
40,000
-29,000
| -42% | -$663K | 0.02% | 818 |
|
|
2014
Q4 | $1.86M | Buy |
69,000
+10,000
| +17% | +$270K | 0.04% | 542 |
|
|
2014
Q3 | $692K | Buy |
59,000
+35,000
| +146% | +$411K | 0.02% | 926 |
|
|
2014
Q2 | $373K | Hold |
24,000
| – | – | 0.01% | 1203 |
|
|
2014
Q1 | $472K | Buy |
+24,000
| New | +$472K | 0.01% | 1103 |
|